Global Influenza Vaccine Market Increasing At A Phenomenal Pace To Reach More Than USD 8,914.5 million USD in 2027

October 2021 | Report Format: Electronic (PDF)

One of the key reasons driving market expansion is a rise in official support & monitoring related influenza immunization on the regional and international levels to oversee the availability, transport, and application of flu shots. Furthermore, increased investment by major market participants across the world, as well as increased government financing, have allowed the development of therapeutically effective vaccinations, driving the flu vaccination market expansion. The creation of a novel vaccination is a lengthy process that typically requires 10-15 years to build and demonstrate its safety and effectiveness. Regulatory restrictions for clinical studies differ by country, which may cause vaccine development to be delayed, limiting future growth.

The growth of the flu vaccine market has aided the growth of the growing immunizations demand. Worldwide, the outbreak has had a significant impact on the flu shot demand; this has had an effect on the industry for influenza vaccinations. Vaccine consumption is increasing as a consequence of their success in preventing illnesses and infections across the globe. Pfizer issued a statement at the start of 2020. With no interruptions in distribution networks, the announcement that Covid 19 vaccinations have been issued has inflated the price of a influenza vaccination marketplace.

Many businesses are assisting with distribution, including F. Hoffmann-La Roche Ltd. and Sanofi, On either side, several nations are experiencing vaccine shortages and delays in vaccine licenses and accessibility as a result of tight restrictions during clinical studies, which are prolonging vaccine delivery timeframes.

Request a Free Sample Copy: Influenza Vaccine Market Report

Influenza Vaccine Market Report Highlights

• Several new formulas have lately been investigated. These formulas comprise large doses of vaccinations and additional quadrivalent vaccinations for older individuals or above the aged of 65. They include MF59 & AS03.
• Sanofi proposed a $736.9 million investment in its Canadian vaccination factory in March 2021 to increase availability of influenza vaccinations in Ontario, the U.s, and Germany. With the goal of increasing supply in such nations, this plant will offer extra antigens and filler capability for Sanofi's Fluzone Elevated Trivalent flu vaccine.
• North America held the biggest share of the flu vaccination industry in 2020 and therefore is anticipated to maintain its dominance during the projected period.

INFLUENZA VACCINE MARKET SEGMENTATION

The research report published by Market Research Strategy contains industry segments, as below-

Influenza Vaccine Type Outlook (Revenue, USD Million, 2016 - 2027)

• Inactivated
• Live Attenuated

Influenza Vaccine Age Outlook (Revenue, USD Million, 2016 - 2027)

• Paediatric
• Adults

Influenza Vaccine, Valency Outlook (Revenue, USD Million, 2016 - 2027)

• Quadrivalent
• Trivalent

Influenza Vaccine Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)

• Government Suppliers
• Hospital & Retail Pharmacies
• Others

Influenza Vaccine Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America (U.S., and Canada)
• Europe (Germany, U.K., France, Italy, Spain etc.)
• Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
• South America (Brazil, Mexico, Argentina etc.)
• Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

List of Key Players- Influenza Vaccine Market

• MYLAN NV
• PFIZER, INC.
• GAMMA VACCINES PTY LTD.
• MERCK & CO., INC. (MERCK SHARP & DOHME CORP.)
• HOFFMANN-LA ROCHE LTD.
• GlaxoSmithKline plc.
• Sanofi S.A
• AstraZeneca
• Seqirus
• BioDiem
• Emergent BioSolutions Inc.
• Sinovac Biotech Ltd
• SERUM INSTITUTE OF INDIA PVT. LTD
• MITSUBISHI TANABE PHARMA
• HUALAN BIOLOGICAL ENGINEERING INC.
• ABBOTT LABORATORIES

About Market Research Strategy:

Market Research Strategy (MRS) is a dedicated and disciplined market research firm that delivers authentic consulting services with accurate data forecasting for research-related services. The positive and result-oriented approaches implemented by us are beneficial in identifying the market challenges of any brand or start-up company to penetrate the competitive business space.

MRS also supports numerous organizations with its syndicate data and research reports to establish and survive in the market by grabbing the available market opportunities. Our vast experience and huge client database turn out to be our wealth and also secures our market position at the top of the list. Besides, we make use of every single piece of information, mined from authentic sources, into a valuable asset of the report; aiding our clients with informed business decisions.

Contact Us:

Market Research Strategy

USA Phone: +1 9176726599

Business Email: sales@marketresearchstrategy.com

Website: https://marketresearchstrategy.com/